Drugs / Allogeneic cord blood treatment
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05515419 | Jul 2025 → Sep 2026 | spinal cord injury, stroke disorder | The Medical Pavilion Bahamas | Withdrawn | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allogeneic cord blood treatment | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05515419 ↗ |